Close Menu

Goldman Sachs

NEW YORK (GenomeWeb News) – Goldman Sachs today resumed coverage of Danaher with a Neutral rating and a 12-month price target of $57.

NEW YORK (GenomeWeb News) – Goldman Sachs has upgraded the stock of Agilent Technologies and Bruker, but downgraded Cepheid and Laboratory Corporation of America.

NEW YORK (GenomeWeb News) – Goldman Sachs today initiated coverage of Genomic Health with a Neutral rating and a six-month price target on its stock of $36.

A constrained funding environment and weaker Euro negatively impacted Affymetrix's gene expression array and eBioscience business units in the third quarter, causing the firm to report lower-than-expected preliminary revenues and eliciting concern from analysts and investors alik

NEW YORK (GenomeWeb News) – Goldman Sachs has placed a Buy rating on Hologic with a six-month price target on its stock of $24, as the Gen-Probe acquisition, completed a week ago, is expected to accelerate top line

NEW YORK (GenomeWeb News) – Becton Dickinson said this week it has declared a quarterly dividend of $45 per share, payable on Sept. 28 to shareholders of record on Sept. 7. The indicated annual dividend rate is $1.80 per share.

NEW YORK (GenomeWeb News) – Despite healthier than expected spending during the second quarter, life science researchers are expected to tighten their purse strings for the remainder of the year, according to the results of a survey conducted by investment firm Goldman Sachs.

NEW YORK (GenomeWeb News) – Goldman Sachs today downgraded Life Technologies and Affymetrix while it upgraded Myriad Genetics and Qiagen.

NEW YORK (GenomeWeb News) – Investment bank Goldman Sachs has reinstated coverage of Illumina, giving it a Neutral rating and a 12-month price target on its stock of $48.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Investment bank Goldman Sachs has revised estimates for a number of firms in its life science tools and diagnostics portfolio in advance of first-quarter earnings announcements.

Pages

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.